Ahs Southcrest Hospital, LLC.
Ahs Southcrest Hospital, LLC. was paid $3.66M by Medicaid between Jan 2018 and Nov 2024, across 52 billing codes. Its largest line is 99285, emergency room visit (most serious) — 44% of everything it billed.
TULSA, OK 74133
Next to other General Acute Care Hospital providers in Oklahoma
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,707 | $344K | |
| 2019 | 3,690 | $352K | |
| 2020 | 2,704 | $211K | |
| 2021 | 5,487 | $479K | |
| 2022 | 11,090 | $879K | |
| 2023 | 11,984 | $1.00M | |
| 2024incomplete | 4,688 | $390K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 44% | 4,937 | 4,843 | $1.60M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 28% | 4,315 | 4,259 | $1.03M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 7.2% | 2,147 | 2,104 | $263K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 7.1% | 1,660 | 1,632 | $261K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 2.6% | 891 | 627 | $95K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.6% | 1,290 | 1,239 | $60K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 1.5% | 116 | 116 | $55K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 1.4% | 12 | 12 | $52K |
| 80053 | Comprehensive metabolic panel | 1.1% | 4,476 | 4,349 | $39K |
| 36415 | Collection of venous blood by venipuncture | 1.1% | 6,454 | 5,994 | $39K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,496 | 5,310 | $35K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 126 | 124 | $20K |
40 more codes
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 2,072 | $16K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,112 | $15K |
| 62323 | <1% | 50 | $14K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 179 | $10K |
| 87428 | <1% | 250 | $7K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 85 | $7K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,111 | $6K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 272 | $5K |
| 83690 | <1% | 643 | $4K | |
| 81001 | <1% | 1,344 | $3K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 529 | $3K |
| 76830 | Ultrasound, transvaginal | <1% | 55 | $3K |
| 81025 | <1% | 473 | $3K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 16 | $1K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 13 | $1K |
| 84484 | <1% | 90 | $1K | |
| 97597 | <1% | 79 | $783.24 | |
| A6196 | Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing | <1% | 87 | $773.86 |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 16 | $612.55 |
| 86850 | <1% | 43 | $356.29 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 51 | $271.92 |
| A6197 | Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing | <1% | 14 | $256.84 |
| 84703 | <1% | 27 | $202.28 | |
| 83735 | <1% | 39 | $200.76 | |
| 94060 | <1% | 13 | $146.59 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 12 | $145.60 |
| 86901 | <1% | 43 | $109.06 | |
| 86900 | <1% | 30 | $74.48 | |
| 87081 | <1% | 12 | $74.03 | |
| 81003 | <1% | 25 | $54.18 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 47 | $34.56 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,229 | $33.42 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 43 | $13.44 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 229 | $3.20 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 604 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 26 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 334 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 41 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 80 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Lovelace Health System, LLC | Albuquerque, NM | $57.71M |
| Lovelace Health System LLC | Albuquerque, NM | $45.27M |
| Southwest Medical Associates, LLC | Albuquerque, NM | $41.40M |
| Lovelace Health System, LLC | Albuquerque, NM | $31.24M |
| Lovelace Health System LLC | Roswell, NM | $20.13M |
| Jacksonville Hospital LLC | Jacksonville, TX | $9.41M |
| Henderson Hospital, LLC | Henderson, TX | $8.52M |
| Athens Hospital, LLC | Athens, TX | $8.32M |
| Etmc Physician Group INC. | Tyler, TX | $8.03M |
| Tyler Regional Hospital LLC | Tyler, TX | $7.94M |
| Lovelace Unm Rehabilitation Hospital LLC | Albuquerque, NM | $6.30M |
| Pocatello Hospital LLC | Pocatello, ID | $6.11M |
| Jacksonville Hospital LLC | Jacksonville, TX | $5.93M |
| Ahs Pryor Hospital, LLC | Pryor, OK | $5.61M |
| Bsa Hospital LLC | Amarillo, TX | $4.96M |
| Pittsburg Hospital LLC | Pittsburg, TX | $4.83M |
| Ahs Claremore Regional Hospital, LLC. | Claremore, OK | $4.81M |
| Ahs Henryetta Hospital LLC | Henryetta, OK | $4.27M |
| Pittsburg Hospital LLC | Pittsburg, TX | $3.98M |
| Topeka Hospital, LLC | Topeka, KS | $3.94M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.